
Sitronix Medical (stock code: 300078), known as Sitronix Medical Technology Co, Ltd, is an enterprise founded in 2003 and headquartered in Wenzhou City, Zhejiang Province. The company's main business focuses on the fields of healthcare informatization, Internet of Things and big data, and is committed to providing solutions for smart healthcare and smart business.
In the field of healthcare informatization, Siltronic has built a smart hospital application ecosystem, realizing the interconnection of hospital systems through an intelligent open platform, constructing the closed-loop management of hospital processes as well as the whole management of single diseases by using the IoT commonality open platform, and providing integrated smart services for clinics, scientific research, quality control, and management through an artificial intelligence open platform. Its products and services have covered more than 1,600 large and medium-sized hospitals nationwide, with a mega production base and more than 1,000 professional and technical talents.
In the field of Internet of Things, the main products of Sixtronic include EAS (electronic merchandise anti-theft system) and RFID (radio frequency identification) related products, involving product development, manufacturing and sales, as well as the development, implementation and service of industry application solutions. In the field of smart business, the company has an integrated platform for EAS, ESL, RFID development and application through cooperation with the Chinese Academy of Sciences RFID Technology Research and Development Center and other scientific research institutions. With the advantages of the whole industry chain from chip R&D, label production and system integration, the company's industry applications cover the fields of supply chain management, retailing, manufacturing, and smart city.
In addition, Strongmedic is also actively involved in the development of the Internet of Things (IoT) communication industry, as well as RFID system and equipment production and construction projects. The company has been honored with the 2021 Provincial Pilot List for the Integration and Development of Advanced Manufacturing and Modern Service Industries, among other accolades. However, it should be noted that the company has also faced some challenges and regulatory penalties in 2024, including a decision on administrative penalties issued by the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission.
data statistics
Relevant Navigation

Focusing on the use of advanced AI technology to provide high-quality, professional medical content generation and search solutions for the healthcare industry, to promote the dissemination and application of medical knowledge.

Pearl AI
An AI company focused on dentistry, utilizing advanced AI technology to improve the efficiency and accuracy of dental practice and provide intelligent solutions to dental clinics worldwide.

CyberKnife Medical
Focusing on the medical field, we provide AI technology solutions and services to promote medical intelligence.

Gravel Technology
Focused on leveraging AI algorithms and genetic technologies, particularly in RNA research, to jointly drive innovative drug discovery and development to address long-unmet clinical needs in areas such as oncology, infections and rare diseases.

Future Technology
The company focuses on digital technology and business innovation in the healthcare industry, building a new generation of healthcare digital solutions and ecosystem based on data and business middleware methodology.

Muscovitum
Focusing on IoT AI field, it is committed to providing intelligent solutions for many industries such as smart home, smart healthcare, smart car and so on through intelligent voice, natural language processing and AI chip technology.

molecular mind
Dedicated to accelerating protein discovery and optimization using AI technology to drive biotech progress.

InSilicon Intelligence
Focuses on utilizing generative artificial intelligence to accelerate drug discovery and development, especially comprehensive solutions in target discovery, drug molecule generation and clinical trial prediction.
No comments...